Angiotensin converting enzyme: History and relevance

Seminars in Perinatology

Volumn 24, Issue 1, 2000, Pages 7-10

  Ferreira, Sérgio H ^a,b  

^a Faculty of the Medicine   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CAPTOPRIL; CHELATING AGENT; DIMERCAPROL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POLYPEPTIDE;

ANTIHYPERTENSIVE THERAPY; CHRONIC DISEASE; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SCLERODERMA;

EID: 0034091641     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-0005(00)80046-4     Document Type: Article

References (31)

1. Tigerstedt R Bergman PG Niere und Krieslau Skand Arch Physiol 8 1898 223 271
2. Goldblatt H Lynch J Hanzal RF Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia J Exp Med 59 1934 347 380
3. Fasciolo JC Houssay BA Taquini AC The blood pressure raising secretion of the ischemic kidney J Physiol 94 1938 281 290
4. Pickering GW Prinzmetal M Some observations on renin, a pressor substance contained in normal kidney, together with a method for its biological assay Clin Sci 3 1938 211 227
5. Muá-áoz JM Braun-Menéndez E Fasciolo JC Hypertensin: The substance causing renal hypertension Nature 144 1939 980 987
6. Braun-Menéndez E Fasciolo JC Leloir LF The substance causing renal hypertension J Physiol 98 1940 283 298
7. Page IH Helmer OR A crystalline pressor substance (angiotonin) resulting from the interaction between renin and renin-activator J Exp Med 71 1940 29 42
8. Goormaghtigh N Facts in favour of an endocrine function of the renal arterioles J Pathol Bacteriol 57 1945 372 385
9. Skeggs LT Kahn JR Shumay NP Preparation and function of the hypertensin-converting enzyme J Exp Med 103 1956 295 305
10. Laragh JH Angers M Kelly WG Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II and other on the secretory rate of aldosterone in man JAMA 174 1960 240 243
11. Ferreira SH Rocha e Silva M Potentiation of bradykinin by dimercaptopropanl (BAL) and other inhibitors of this destroyingenzyme in plasma Biochem Pharmacol 11 1962 1123 1128
12. Erdös EG Wohler JR Inhibition “in vivo” of the enzymatic inactivation of bradykinin and kallidin Biochem and Pharmacol 12 1963 1193
13. Erdös EG Sloane EM An enzyme in human blood plasma that inactivates bradykinin and kallidin Biochem and Pharmacol 11 1962 585 592
14. Ferreira SH A bradykinin-potentiating factor (BPF) present in the venom of Bothrops Jararaca Br J Pharmacol 24 1965 163 169
15. Ferrira SH Bradykin-potentiating factor Erdö EG Back N Sicuteri F Hypotensive Peptides 1966 Springer-Verlag New York, NY 356 367
16. Ferrira SH Rocha e Silva M Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops Jararaca venom Experientia 21 1965 347 349
17. Graeff FG Ferreira SH Corrado AP Potentiation of the cerebral vascular action of bradykinin by the “bradykinin potentiating factor” (BPF) in the dog Experimentia 21 1965 607 608
18. Ferreira SH Vane JR The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat Br J Pharmacol Chemo 30 1967 417 424
19. Ferreira SH Vane JR The detection and estimation of bradykinin in the circulating blood Br J Pharmacol Chemo 29 1967 367 377
20. Bahkle YS Conversion of angiotensin I to angiotensin II by cell-free extracts of drug lung Nature 220 1968 919 921
21. Bahkle YS Reynard AM Vane JR Metabolism of the angiotensins in isolated perfused tissues Nature 222 1969 956 957
22. Ferreira SH Bartelt DC Greene LJ Isolation of bradykinin-potentiating peptides from Bothrops Jararaca venom Biochemistry 9 1970 2583 2593
23. Ferreira SH Greene LJ Alabaster VA Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme Nature 225 1970 379 380
24. Greene LJ Stewart JM Ferreira SH Bradykinin-potentiating peptides from the venom of Bothrops Jararaca Sicuteri F Rocha e Silva M Back N Bradykinin and Related Kinins: Cardiovascular Biochemical and Neural Actions, vol 8 1970 Plenum Press New York, NY 81 87
25. Stewart JM Ferreira SH Greene LJ Bradykinin potentiating peptide PCA-Lys-TRP-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I and II Biochem Pharmacol 20 1971 1557 1567
26. Krieger EM Salgado HC Assan CJ Potential screening test for detection of overactivity of renin-angiotensin system Lancet 1 1971 269 271
27. Ondetti MA Williams NJ Sabo EF Angiotensin-converting enzyme inhibitors from the venom of Bothrops Jararaca. Isolation, elucidation of structure and synthesis Biochemistry 10 1971 4033 4039
28. Greene LJ Camargo ACM Krieger EM Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops Jararaca venom Circ Res 30 1972 62 71
29. Gravas H Brunner HR Laragh J An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients New Engl J Med 291 1974 817 821
30. Byers LD Wolfenden R A potent reversible inhibitor of carboxypeptidase A J Biol Chem 247 1972 606 608
31. Cushman DW Cheung HS Sabo EF Design of potent competitive inhibitors of angiotensin-converting enzyme carboxyalkanoyl and mercaptoalkanoyl amino acids Biochemistry 16 1977 5484 5491